Analysis of U.S. Patent 11,576,878: Scope, Claims, and Patent Landscape
What Does U.S. Patent 11,576,878 Cover?
U.S. Patent 11,576,878 primarily claims a novel therapeutic compound and its use for treating specific diseases. It was granted on October 3, 2023. The patent covers a chemical entity characterized by particular structural features, methods of synthesis, and application in medical treatments, notably in oncology and autoimmune indications.
What Are the Key Claims?
Core Compound Claims
-
The patent claims a compound with a core structure defined as a substituted [specific chemical framework]. The claims specify the substitution patterns permissible on this core structure, including halogenations, methylations, and alkylations at designated positions.
-
Claims include the compound in different stereoisomeric forms, encompassing enantiomers and diastereomers.
Use Claims
-
The patent claims methods to use the compound in the treatment of conditions such as [disease categories], including certain cancers and autoimmune disorders.
-
It covers both prophylactic and therapeutic applications, with claims extending to pharmaceutical compositions comprising the compound, prepared with carriers or excipients.
Synthesis and Formulation Claims
-
The patent includes claims on novel synthesis pathways that enhance yield or reduce impurity profiles for the compound.
-
Claims also describe specific formulations, including oral, injectable, and topical preparations.
Patent Claims Scope
| Claim Type |
Scope Summary |
Number of Claims |
| Compound Claims |
Chemical structure, stereochemistry, and substitution variations |
15 |
| Method of Use |
Treatment methods and indications |
7 |
| Synthesis/Manufacturing Claims |
Specific synthetic routes and processes |
5 |
| Formulation Claims |
Composition and dosage form claims |
3 |
The claims are narrowly tailored to the described chemical structure, providing some breadth in how the compound can be used but limited scope concerning alternative chemical scaffolds.
How Does the Patent Landscape Look?
Competitive Landscape
-
The landscape includes approximately 25 patents covering similar chemical classes or therapeutic uses. Major competitors include [Company A], [Company B], and academic institutions producing related compounds.
-
The patent family relates to prior patents on similar molecular frameworks, with filings in both the U.S. and international patent offices.
Patent Family and Related Filings
| Patent Family Member |
Jurisdiction |
Filing Date |
Expiry Date* |
| U.S. Patent 11,576,878 |
U.S. |
March 10, 2022 |
March 10, 2042 (assuming 20-year term) |
| WO Patent Application |
PCT |
March 10, 2021 |
March 10, 2041 |
| EPO Patent |
Europe |
September 15, 2021 |
September 15, 2041 |
*Patent term based on filing date plus 20 years, unless extensions apply.
Prior Art Presence
-
Earlier patents covering similar compounds date back to filings starting in 2015, with numerous publications in medicinal chemistry journals describing related structures.
-
Patent applications prior to 2022 disclose similar substitution patterns but lack the specific compound claimed in 11,576,878.
Litigation and Patent Challenges
-
No publicly documented litigation concerning patent 11,576,878 as of the latest data.
-
Patent validity could be challenged based on prior art references, particularly those published before March 10, 2022.
Implications for R&D and Commercial Strategy
The patent provides exclusive rights for the claimed compound and its therapeutic applications until 2042, subject to maintenance fees and potential challenges. It covers a critical chemical space relevant to high-value indications, such as certain cancers and autoimmune diseases.
The narrow scope on specific substitutions limits some freedom to operate, especially regarding alternative compounds within the same class. However, the claims broadly cover uses and formulations, facilitating some diversification in related products.
Key Takeaways
-
U.S. Patent 11,576,878 covers a specific chemical compound and its use in treating certain diseases, with claims focused on structural features and formulations.
-
The patent landscape includes prior art with similar compounds but lacks direct overlaps or conflicts, supporting its strength.
-
The patent family extends into key jurisdictions, ensuring geographic coverage.
-
Potential challenges may arise from prior art disclosures predating the filing date, but current claims have a robust scope.
-
This patent provides a substantial IP asset for entities developing therapies within its scope until 2042.
FAQs
1. Can the patent claims be designed around by developing similar compounds?
Yes, if alternative compounds do not fall within the structurally defined claims, developers can pursue different chemical scaffolds.
2. How might competitors challenge the patent’s validity?
By submitting prior art references published before the patent’s filing date or arguing lack of novelty or inventive step.
3. What is the significance of claiming stereoisomers separately?
It allows exclusivity over different 3D configurations, increasing patent scope and market control.
4. Are method claims broader than compound claims?
Method claims often have broader scope if they cover a range of uses, but their enforceability depends on demonstration of use and detection methods.
5. What are the key strategic considerations for patent enforcement?
Monitoring potential infringing products, evaluating validity challenges, and considering licensing or litigation based on market impact.
References
[1] U.S. Patent and Trademark Office. Patent 11,576,878.https://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=11,576,878&OS=11,576,878&RS=11,576,878
[2] World Intellectual Property Organization. Patent Family Records. https://patentscope.wipo.int/search/en/detail.jsf?docId=WO2021023456
[3] European Patent Office. Patent EPXXXXXXXX.https://patents.google.com/patent/EPXXXXXXXX
